🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has taken down problematic content and banned related hashtags and search suggestions. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.

Within minutes of entering one community, a seller posted contact information, where the majority of transactions take place. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious medical dangers”.